Discover 153 paid clinical trials in College Station, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 153
Featured
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Tomball TX, Houston TX, Pasadena TX, San Antonio TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351058
Phase3, Recruiting
Featured
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: Tomball TX, Lake Charles LA, Houston TX, Tamarac FL
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07620392
Phase2, Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
for
Depression, Bipolar I Disorder
Location: The Woodlands TX, Richmond TX, Houston TX, Bellaire TX,
Sponsor: AbbVie
Sex: All
Age: 10 - 17
Code: NCT04777357
Phase3, Recruiting
Active & Responsive
Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring
for
Insulin Response, Type 1 Diabetes (T1D)
Location: College Station TX
Sponsor: Texas A&M University
Sex: All
Age: 18 - 70+
Code: NCT07254364
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Anabolic Response to Beef vs Plant Protein in (Pre)Frail Older Adults Using a Novel Stable Isotope Pulse Method
for
Protein Metabolism
Location: College Station TX
Sponsor: Texas A&M University
Sex: All
Age: 65 - 70+
Code: NCT07254403
Recruiting
Active & ResponsiveNew
Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS)
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
for
Graves' Disease
Location: Conroe TX, Houston TX, Humble TX, San Antonio TX,
Sponsor: Yarrow Bioscience, Inc.
Sex: All
Age: 18+
Code: NCT07682896
Phase2, Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Tomball TX, Kingwood TX, Humble TX, Round Rock TX,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Recruiting
Active & Responsive
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: Tomball TX, Houston TX, DeSoto TX, San Antonio TX,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase3, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
for
Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Tomball TX, Fairhope AL, Miami Lakes FL, Stoney Creek,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07761117
Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
for
Rheumatoid Arthritis
Location: Tomball TX, Lake Charles LA, Houston TX, Colleyville TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07137598
Phase2, Recruiting
Active & Responsive
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD